News & Events
ERC Advanced Grant for Ferdinand von Meyenn
Ferdinand von Meyenn is one of five researchers at ETH Zurich to have been awarded an ERC Advanced Grant. In his project, he will develop methods to specifically alter epigenetic traces in cells. Congratulations!
Alexander Mathys admitted to the Berlin-Brandenburg Academy of Sciences and Humanities
The Associate Professor at the Department of Health Sciences and
Technology (D-HEST) has been accepted as a member of the
Berlin-Brandenburg Academy of Sciences and Humanities. Congratulations!
Light-controlled pore formation for better organoid growth
Researchers at the Department of Health Sciences and Technology at ETH Zurich have developed an innovative method for the production of cell-guiding microporous hydrogels. This type of structured biomaterials can significantly improve the growth and function of cells in 3D cultures. The new technique makes it possible to precisely control the tiny pores in these cell-friendly scaffolds.
Study demonstrates benefits of molecular tumour analysis
Every tumour is unique. This makes it difficult to find the most effective therapy for treatment. Researchers in Zurich and Basel are now showing how state-of-the-art molecular biological technologies can be used to create a detailed tumour profile within four weeks, enabling tailored treatment. The study is the first of its kind in the world. Bernd Wollscheid from the Department of Health Sciences and Technology contributed to the study.
Despite Trump’s bold claims, medicine prices in Europe won’t rise anytime soon
Kerstin Noëlle Vokinger explains in an article in swissinfo how drug prices are regulated in Switzerland and why drug prices in Europe can't just rise at the flip of a switch.